185 related articles for article (PubMed ID: 31281982)
21. Relation of plasma fatty acid binding proteins 4 and 5 with the metabolic syndrome, inflammation and coronary calcium in patients with type-2 diabetes mellitus.
Bagheri R; Qasim AN; Mehta NN; Terembula K; Kapoor S; Braunstein S; Schutta M; Iqbal N; Lehrke M; Reilly MP
Am J Cardiol; 2010 Oct; 106(8):1118-23. PubMed ID: 20920650
[TBL] [Abstract][Full Text] [Related]
22. Total body fat, abdominal fat, body fat distribution and surrogate markers for health related to adipocyte fatty acid-binding protein (FABP4) in children.
Dencker M; Danielson A; Karlsson MK; Wollmer P; Andersen LB; Thorsson O
J Pediatr Endocrinol Metab; 2017 Apr; 30(4):375-382. PubMed ID: 28085673
[TBL] [Abstract][Full Text] [Related]
23. Curcumin nanoparticles potentiate therapeutic effectiveness of acitrein in moderate-to-severe psoriasis patients and control serum cholesterol levels.
Bilia AR; Bergonzi MC; Isacchi B; Antiga E; Caproni M
J Pharm Pharmacol; 2018 Jul; 70(7):919-928. PubMed ID: 29600580
[TBL] [Abstract][Full Text] [Related]
24. Decreased Systemic Levels of Endocan-1 and CXCL16 in Psoriasis Are Restored following Narrowband UVB Treatment.
Sigurdardottir G; Ekman AK; Verma D; Enerbäck C
Dermatology; 2018; 234(5-6):173-179. PubMed ID: 30176661
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of Tripterygium wilfordii hook F versus acitretin in moderate to severe psoriasis vulgaris: a randomized clinical trial.
Wu C; Jin HZ; Shu D; Li F; He CX; Qiao J; Yu XL; Zhang Y; He YB; Liu TJ
Chin Med J (Engl); 2015 Feb; 128(4):443-9. PubMed ID: 25673443
[TBL] [Abstract][Full Text] [Related]
26. Adipocyte Fatty-Acid Binding Protein is Overexpressed in Cirrhosis and Correlates with Clinical Outcomes.
Graupera I; Coll M; Pose E; Elia C; Piano S; Solà E; Blaya D; Huelin P; Solé C; Moreira R; de Prada G; Fabrellas N; Juanola A; Morales-Ruiz M; Sancho-Bru P; Villanueva C; Ginès P
Sci Rep; 2017 May; 7(1):1829. PubMed ID: 28500294
[TBL] [Abstract][Full Text] [Related]
27. [Relations of serum adipocyte fatty acid binding protein to sex hormone and lipoproteins in patients with polycystic ovary syndrome].
Hu WH; Qiao J; Li R; Wang LN
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(45):3186-9. PubMed ID: 17313783
[TBL] [Abstract][Full Text] [Related]
28. Algorithm to select optimal systemic anti-psoriatic drugs in relation with patients' Psoriasis Area and Severity Index score for plaque psoriasis.
Bae SH; Yun SJ; Lee JB; Kim SJ; Won YH; Lee SC
J Dermatol; 2016 Jun; 43(6):643-9. PubMed ID: 26598783
[TBL] [Abstract][Full Text] [Related]
29. Adipocyte fatty acid-binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome.
Xu A; Wang Y; Xu JY; Stejskal D; Tam S; Zhang J; Wat NM; Wong WK; Lam KS
Clin Chem; 2006 Mar; 52(3):405-13. PubMed ID: 16423904
[TBL] [Abstract][Full Text] [Related]
30. Lipoprotein apheresis reduces adipocyte fatty acid-binding protein serum levels.
Lamounier-Zepter V; Look C; Ehrhart-Bornstein M; Bornstein SR; Fischer S; Julius U
Atheroscler Suppl; 2013 Jan; 14(1):129-34. PubMed ID: 23357154
[TBL] [Abstract][Full Text] [Related]
31. The role of etanercept on the expression of markers of T helper 17 cells and their precursors in skin lesions of patients with psoriasis vulgaris.
Antiga E; Volpi W; Chiarini C; Cardilicchia E; Filì L; Manuelli C; Parrochi P; Fabbri P; Caproni M
Int J Immunopathol Pharmacol; 2010; 23(3):767-74. PubMed ID: 20943046
[TBL] [Abstract][Full Text] [Related]
32. [Expression and significance of adipocyte fatty acid-binding protein in placenta, serum and umbilical cord blood in preeclampsia].
Yan JY; Wang XJ
Zhonghua Fu Chan Ke Za Zhi; 2010 Dec; 45(12):885-90. PubMed ID: 21211417
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
34. HLA-G 14-bp polymorphism: a possible marker of systemic treatment response in psoriasis vulgaris? Preliminary results of a retrospective study.
Borghi A; Rizzo R; Corazza M; Bertoldi AM; Bortolotti D; Sturabotti G; Virgili A; Di Luca D
Dermatol Ther; 2014; 27(5):284-9. PubMed ID: 24909182
[TBL] [Abstract][Full Text] [Related]
35. Serum fatty acid profile in psoriasis and its comorbidity.
Myśliwiec H; Baran A; Harasim-Symbor E; Myśliwiec P; Milewska AJ; Chabowski A; Flisiak I
Arch Dermatol Res; 2017 Jul; 309(5):371-380. PubMed ID: 28585093
[TBL] [Abstract][Full Text] [Related]
36. Serum fatty acid-binding protein 4 is a predictor of cardiovascular events in end-stage renal disease.
Furuhashi M; Ishimura S; Ota H; Hayashi M; Nishitani T; Tanaka M; Yoshida H; Shimamoto K; Hotamisligil GS; Miura T
PLoS One; 2011; 6(11):e27356. PubMed ID: 22102888
[TBL] [Abstract][Full Text] [Related]
37. Impact of Elevated Serum Uric Acid Levels on Systemic Inflammation in Patients With Psoriasis.
Solak B; Dikicier BS; Erdem T
Angiology; 2017 Mar; 68(3):266-270. PubMed ID: 27401209
[TBL] [Abstract][Full Text] [Related]
38. Vascular endothelial growth factor in psoriasis: an indicator of disease severity and control.
Nofal A; Al-Makhzangy I; Attwa E; Nassar A; Abdalmoati A
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):803-6. PubMed ID: 19309427
[TBL] [Abstract][Full Text] [Related]
39. Systolic blood pressure and fatty acid-binding protein 4 predict pregnancy-induced hypertension in overweight nulliparous women.
Tuuri AL; Jauhiainen MS; Tikkanen MJ; Kaaja RJ
Placenta; 2014 Oct; 35(10):797-801. PubMed ID: 25130095
[TBL] [Abstract][Full Text] [Related]
40. [Relations between serum adipocyte fatty acid-binding protein and type 2 diabetes in a community population].
YE WH; PENG XH; AI YQ; CHEN H; ZHANG H; CAI DH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):508-11. PubMed ID: 21421494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
